IP Library Granted Patent US 8,883,408
Granted Patent B2
US 8,883,408 · App. 13/754,029 · Granted Nov 11, 2014

Tissue implants for implantation and methods of preparing the same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,883,408
App. No.
13/754,029
Granted
Nov 11, 2014
Kind
B2
Abstract

A method is provided for preparing a tissue implant for implantation. The method includes harvesting a tissue material from a human or an animal donor, treating the tissue material in a nuclease-containing solution, and thereafter treating the tissue material with an alkaline alcohol solution. The nuclease-containing solution includes an antimicrobial. The alkaline alcohol solution comprises sodium hydroxide and ethanol.

Claims (28)

1. A method of preparing a tissue implant for implantation comprising:

treating a decellularized tissue material with an alkaline alcohol solution comprising an alkaline component in an amount from about 0.016 M to about 0.022 M,

wherein the tissue material comprises mammalian pericardium.

2. The method of claim 1 , wherein the alkaline alcohol solution comprises ethanol.

3. The method of claim 2 , wherein the ethanol is present in a concentration of about 72 to about 88 percent v/v.

4. The method of claim 1 , wherein the alkaline component comprises a hydroxide salt.

5. The method of claim 4 , wherein the hydroxide salt comprises sodium hydroxide.

6. The method of claim 5 , wherein the alkaline alcohol solution is about 0.020 M sodium hydroxide.

7. The method of claim 1 , wherein the alkaline alcohol solution comprises ethanol in a concentration from about 72 to about 88 percent v/v and about 0.016 M to about 0.022 M sodium hydroxide.

8. The method of claim 1 , wherein the decellularized tissue material is treated with the alkaline alcohol solution for about 60 minutes to about 3 hours.

9. The method of claim 1 , wherein the decellularized tissue material comprises human, bovine, porcine, or equine pericardium.

10. A method of preparing a tissue implant for implantation comprising:

treating a decellularized tissue material with an alkaline alcohol solution comprising an alkaline component in an amount from about 0.016 M to about 0.022 M; and thereafter

treating the decellularized tissue material with a chlorine dioxide solution.

11. The method of claim 10 , wherein the alkaline alcohol solution comprises ethanol.

12. The method of claim 11 , wherein the ethanol is present in a concentration of about 72 to about 88 percent v/v.

13. The method of claim 10 , wherein the alkaline component comprises sodium hydroxide.

14. The method of claim 13 , wherein the alkaline alcohol solution is about 0.02 M sodium hydroxide.

15. The method of claim 10 , wherein the alkaline alcohol solution comprises ethanol in a concentration from about 72 to about 88 percent v/v and about 0.016 M to about 0.022 M sodium hydroxide.

16. The method of claim 10 , wherein the decellularized tissue material is treated with the alkaline alcohol solution for about 60 minutes to about 3 hours.

17. The method of claim 10 , wherein during the treatment with the chlorine dioxide treatment solution, the chlorine dioxide treatment solution comprises greater than about 50 ppm chlorine dioxide for about 60 minutes or longer.

18. A method of preparing a tissue implant for implantation comprising:

treating a decellularized tissue material with an alkaline alcohol solution comprising sodium hydroxide and ethanol, wherein the ethanol is present in the alkaline alcohol solution in a concentration from about 72 to about 88 percent v/v and the alkaline alcohol solution comprises about 0.016 M to about 0.022 M sodium hydroxide.

19. The method of claim 18 , wherein the decellularized tissue material comprises human, bovine, porcine, or equine pericardium.

20. A method of preparing a tissue implant for implantation comprising:

treating a decellularized tissue material with an alkaline alcohol solution comprising from about 0.016 M to about 0.022 sodium hydroxide and ethanol for about 60 minutes to about 3 hours; and thereafter

treating the decellularized tissue material with a chlorine dioxide solution comprising greater than about 50 ppm chlorine dioxide for about 60 minutes or longer;

wherein the decellularized tissue material comprises mammalian pericardium.

Assignments (7)
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS Recorded Jan 22, 2024
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: CRYOLIFE, INC.; ON-X LIFE TECHNOLOGIES, INC.
Reel/Frame 066360/0562 →
SECURITY INTEREST Recorded Jan 18, 2024
From: ARTIVION, INC.
To: ARES CAPITAL CORPORATION
Reel/Frame 066159/0893 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Dec 1, 2017
From: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS ADMINISTRATIVE AGENT
To: CRYOLIFE, INC.; CRYOLIFE ACQUISITION CORPORATION; CARDIOGENESIS CORPORATION (N/K/A CRYOLIFE, INC.); HEMOSPHERE, INC.; ON-X LIFE TECHNOLOGIES, INC. (F/K/A MCRI, INC.); VALVE SPECIAL PURPOSE CO., LLC
Reel/Frame 044621/0240 →
PATENT SECURITY AGREEMENT Recorded Dec 1, 2017
From: CRYOLIFE, INC.; ON-X LIFE TECHNOLOGIES, INC. (F/K/A MCRI, INC.)
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 044616/0940 →
SECURITY INTEREST Recorded Jan 21, 2016
From: CRYOLIFE, INC., AS GRANTOR; VALVE SPECIAL PURPOSE CO., LLC, AS GRANTOR; ON-X LIFE TECHNOLOGIES, INC., AS GRANTOR
To: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS AGENT
Reel/Frame 037569/0212 →
ASSIGNMENT OF INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Nov 19, 2015
From: GENERAL ELECTRIC CAPITAL CORPORATION, AS RETIRING AGENT
To: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS SUCCESSOR AGENT
Reel/Frame 037146/0466 →
SECURITY INTEREST Recorded Sep 29, 2014
From: CRYOLIFE, INC.; HEMOSPHERE, INC.; CARDIOGENESIS CORPORATION
To: GENERAL ELECTRIC CAPITAL CORPORATON, AS AGENT
Reel/Frame 033835/0742 →